{"Title": "Cancer evolution constrained by mutation order", "Year": 2015, "Source": "New Engl. J. Med.", "Volume": "372", "Issue": 7, "Art.No": null, "PageStart": 661, "PageEnd": 663, "CitedBy": 18, "DOI": "10.1056/NEJMe1414288", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922696890&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["DNA-Binding Proteins", "Hematopoietic Stem Cells", "Humans", "Janus Kinase 2", "Mutation", "Myeloproliferative Disorders", "Proto-Oncogene Proteins"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84922696890", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"7005912775": {"Name": "Swanton C.", "AuthorID": "7005912775", "AffiliationID": "60024544", "AffiliationName": "University College London Hospitals, Cancer Institute"}}}